Home/selectION Therapeutics/Antonius Schuh

AS

Antonius Schuh

CEO

selectION Therapeutics

Roles

CEOatselectION Therapeutics

Chairman of the BoardatOmnix Medical

Therapeutic Areas

Autoimmune Diseases Dermatology Rheumatology Gastroenterology Neurology

selectION Therapeutics Pipeline

Drug	Indication	Phase
si-544	Psoriasis Vulgaris, Atopic Dermatitis, and other T cell-mediated autoimmune diseases	Phase 2 (planning)

Leadership Team at selectION Therapeutics

Dr. Fred Ramsdell

Scientific Advisor

View full selectION Therapeutics profile